145 related articles for article (PubMed ID: 27028306)
1. Potency and stability of compounded cyclophosphamide: a pilot study.
Robat C; Budde J
Vet Comp Oncol; 2017 Sep; 15(3):706-709. PubMed ID: 27028306
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy.
Karara AH; Hines R; Demir Z; Nnorom B; Horsey R; Twigg G
Int J Pharm Compd; 2016; 20(6):461-467. PubMed ID: 28339384
[TBL] [Abstract][Full Text] [Related]
3. Frequency and Severity of Neutropenia Associated with Food and Drug Administration Approved and Compounded Formulations of Lomustine in Dogs with Cancer.
Burton JH; Stanley SD; Knych HK; Rodriguez CO; Skorupski KA; Rebhun RB
J Vet Intern Med; 2016; 30(1):242-6. PubMed ID: 26682700
[TBL] [Abstract][Full Text] [Related]
4. Effects of cyclophosphamide in dogs and cats.
Stanton ME; Legendre AM
J Am Vet Med Assoc; 1986 Jun; 188(11):1319-22. PubMed ID: 3721990
[No Abstract] [Full Text] [Related]
5. Phase I dose escalating study of oral cyclophosphamide in tumour-bearing cats.
Chan CM; Rassnick KM; Frimberger AE; Nguyen SM; Moore AS
Vet J; 2020 Apr; 258():105450. PubMed ID: 32564869
[TBL] [Abstract][Full Text] [Related]
6. Potency and stability of compounded formulations of chlorambucil, melphalan and cyclophosphamide.
Burton JH; Knych HK; Stanley SD; Rebhun RB
Vet Comp Oncol; 2017 Dec; 15(4):1558-1563. PubMed ID: 28120478
[TBL] [Abstract][Full Text] [Related]
7. Extemporaneous compounding in veterinary practice: a New Zealand perspective.
Gargiulo DA; Chemal C; Joda L; Lee YJ; Pilkington M; Haywood A; Garg S
N Z Vet J; 2013 Nov; 61(6):311-5. PubMed ID: 23544952
[TBL] [Abstract][Full Text] [Related]
8. Immunological and angiogenic markers during metronomic temozolomide and cyclophosphamide in canine cancer patients.
Denies S; Cicchelero L; de Rooster H; Daminet S; Polis I; Van de Maele I; Sanders NN
Vet Comp Oncol; 2017 Jun; 15(2):594-605. PubMed ID: 26961119
[TBL] [Abstract][Full Text] [Related]
9. The use of cytotoxic agents in the treatment of immune-mediated diseases of dogs and cats.
Miller E
Semin Vet Med Surg Small Anim; 1997 Aug; 12(3):157-60. PubMed ID: 9283239
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of low-dose metronomic (LDM) cyclophosphamide toxicity in cats with malignant neoplasia.
Leo C; Stell A; Borrego J; Martinez de Merlo E; Ruess-Melzer K; Lara-Garcia A
J Feline Med Surg; 2014 Aug; 16(8):671-8. PubMed ID: 24423814
[TBL] [Abstract][Full Text] [Related]
11. A clinical protocol for treatment of canine mammary tumors using encapsulated, cytochrome P450 synthesizing cells activating cyclophosphamide: a phase I/II study.
Winiarczyk S; Gradski Z; Kosztolich B; Gabler C; König G; Renner M; Saller RM; Prosl H; Salmons B; Günzburg WH; Hain J
J Mol Med (Berl); 2002 Sep; 80(9):610-4. PubMed ID: 12226743
[No Abstract] [Full Text] [Related]
12. Cytotoxic drug use in treatment of dogs and cats with cancer by UK veterinary practices (2003 to 2004).
Cave TA; Norman P; Mellor D
J Small Anim Pract; 2007 Jul; 48(7):371-7. PubMed ID: 17559520
[TBL] [Abstract][Full Text] [Related]
13. Incidence of sterile hemorrhagic cystitis in tumor-bearing dogs concurrently treated with oral metronomic cyclophosphamide chemotherapy and furosemide: 55 cases (2009-2015).
Chan CM; Frimberger AE; Moore AS
J Am Vet Med Assoc; 2016 Dec; 249(12):1408-1414. PubMed ID: 27901449
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy of tumors in dogs].
Austie BA; Rutteman GR; Misdorp W
Tijdschr Diergeneeskd; 1988 Mar; 113(6):299-310. PubMed ID: 3283998
[TBL] [Abstract][Full Text] [Related]
15. The role of clinical trials in veterinary oncology.
Burton J; Khanna C
Vet Clin North Am Small Anim Pract; 2014 Sep; 44(5):977-87. PubMed ID: 25174911
[TBL] [Abstract][Full Text] [Related]
16. Dosage escalation of intravenous cyclophosphamide in cats with cancer.
Moore AS; Frimberger AE; Chan CM
Vet J; 2018 Dec; 242():39-43. PubMed ID: 30503542
[TBL] [Abstract][Full Text] [Related]
17. The Use of Liposomes and Nanoparticles as Drug Delivery Systems to Improve Cancer Treatment in Dogs and Cats.
Zabielska-Koczywąs K; Lechowski R
Molecules; 2017 Dec; 22(12):. PubMed ID: 29215573
[TBL] [Abstract][Full Text] [Related]
18. Cats and chemotherapy: treat as 'small dogs' at your peril.
Kent MS
J Feline Med Surg; 2013 May; 15(5):419-24. PubMed ID: 23603505
[TBL] [Abstract][Full Text] [Related]
19. Furosemide for prevention of cyclophosphamide-associated sterile haemorrhagic cystitis in dogs receiving metronomic low-dose oral cyclophosphamide.
Setyo L; Ma M; Bunn T; Wyatt K; Wang P
Vet Comp Oncol; 2017 Dec; 15(4):1468-1478. PubMed ID: 28194917
[TBL] [Abstract][Full Text] [Related]
20. Treatment of metastasis.
Jeglum KA
Vet Clin North Am Small Anim Pract; 1985 May; 15(3):659-66. PubMed ID: 3874470
[No Abstract] [Full Text] [Related]
[Next] [New Search]
